Earlier quoted context omitted.
No, that has nowhere near the same efficacy.
C19ivermectin.com - which includes well done and poorly done studies - lists 86% reduction with prophylaxis treatment. You'll believe and weight a single study done by the company looking to make billions via a new patented drug over many third-party studies of a cheap off-patent drug though, won't you?
https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111...